0.5833
Xtant Medical Holdings Inc stock is traded at $0.5833, with a volume of 97,678.
It is down -1.30% in the last 24 hours and down -17.20% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.591
Open:
$0.583
24h Volume:
97,678
Relative Volume:
0.44
Market Cap:
$81.66M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
58.33
EPS:
0.01
Net Cash Flow:
$-12.42M
1W Performance:
+2.33%
1M Performance:
-17.20%
6M Performance:
-12.94%
1Y Performance:
+4.16%
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings Inc
|
0.5833 | 82.74M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Sentiment Review: Is Xtant Medical Holdings Inc gaining market shareJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Aug Volume: Can Xtant Medical Holdings Inc navigate macro headwindsMarket Weekly Review & AI Driven Stock Movement Reports - baoquankhu1.vn
Investment Report: Can Xtant Medical Holdings Inc deliver consistent dividendsPortfolio Value Summary & Target Return Focused Stock Picks - baoquankhu1.vn
Retail Surge: Is Xtant Medical Holdings Inc stock overvalued or fairly pricedJuly 2025 Short Interest & Expert Curated Trade Setups - baoquankhu1.vn
Trading Recap: Will Xtant Medical Holdings Inc benefit from rising consumer demandWeekly Trade Review & Expert Curated Trade Setups - baoquankhu1.vn
FOMO Trade: Is Xtant Medical Holdings Inc stock overvalued or fairly pricedNew Guidance & Low Risk Entry Point Guides - baoquankhu1.vn
Moving Averages: What hedge funds are buying Xtant Medical Holdings IncInflation Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 25.3% in January - MarketBeat
Bank Watch: Is Xtant Medical Holdings Inc stock a value trapDay Trade & Stepwise Trade Execution Plans - baoquankhu1.vn
Shorts Report: Is Xtant Medical Holdings Inc stock a top performer YTD2025 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Published on: 2026-01-27 00:29:06 - baoquankhu1.vn
Xtant Medical Reports Strong Q3 2025 Results - MSN
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Volume Summary: Is Xtant Medical Holdings Inc stock a value trapJuly 2025 Retail & Weekly High Return Forecasts - baoquankhu1.vn
US Market Recap: Will Xtant Medical Holdings Inc benefit from government policyJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - baoquankhu1.vn
Xtant Medical Extends Note Maturity After Asset Divestitures - TipRanks
Xtant Medical Extends Note Maturity and Adjusts Payment Timing - TradingView
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Drop in Short Interest - MarketBeat
Will Xtant Medical Holdings Inc. stock beat EPS estimates2025 Price Action Summary & Daily Stock Trend Watchlist - Улправда
Xtant Medical (NYSEAMERICAN:XTNT) Stock Passes Above 200 Day Moving Average – Here’s Why - Defense World
Will Xtant Medical Holdings Inc. stock sustain high P E ratiosQuarterly Earnings Summary & AI Driven Stock Price Forecasts - Улправда
Is Xtant Medical Holdings Inc. stock a defensive play in 2025Quarterly Market Summary & AI Driven Stock Reports - Улправда
Is Xtant Medical Holdings Inc. stock overvalued by current metricsWeekly Gains Summary & Reliable Entry Point Alerts - Улправда
Published on: 2026-01-09 08:10:37 - ulpravda.ru
Will Xtant Medical Holdings Inc. stock split again soonQuarterly Performance Summary & Real-Time Chart Pattern Alerts - Улправда
Published on: 2026-01-07 23:07:16 - ulpravda.ru
Gains Recap: Is Xtant Medical Holdings Inc stock overvalued by current metricsJuly 2025 Momentum & AI Powered Buy/Sell Recommendations - Bộ Nội Vụ
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Can GPT Healthcare Limited Regain Lost Ground This QuarterMarket Depth Overview & Low Cost Portfolio Growth - bollywoodhelpline.com
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Up 286.3% in December - MarketBeat
Aro Granite Industries Limited Bounces Off Moving Average SupportMACD Trading Signals & Rapid Capital Gain - earlytimes.in
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Will Xtant Medical Holdings Inc. (XMS) stock remain on Wall Street radarBuy Signal & Smart Money Movement Tracker - Улправда
Published on: 2025-12-20 11:07:26 - Улправда
Signal Recap: Will Xtant Medical Holdings Inc. stock beat EPS estimatesWeekly Trend Report & Real-Time Market Sentiment Alerts - Улправда
Is Xtant Medical Holdings Inc. stock a dividend growth opportunity2025 Support & Resistance & Daily Stock Trend Reports - DonanımHaber
History Review: How Xtant Medical Holdings Inc. stock performs in weak economyJuly 2025 Price Swings & Smart Money Movement Tracker - DonanımHaber
Published on: 2025-12-19 12:58:44 - Улправда
Aug Weekly: Is Xtant Medical Holdings Inc. (XMS) stock a momentum leaderShort Setup & Free Daily Entry Point Trade Alerts - Улправда
Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT), Novan (NOVN) and Adaptive Biotechnologies (ADPT) - The Globe and Mail
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
AWM Investment Company Inc. Takes $4.88 Million Position in Xtant Medical Holdings, Inc. $XTNT - MarketBeat
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Xtant Medical Debuts Next-Gen Synthetic Bone Graft - Precedence Research
Xtant Medical launches next-generation synthetic bone graft - Investing.com
Xtant Medical launches next-generation synthetic bone graft By Investing.com - Investing.com South Africa
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata Synthetic Bone Graft - Finviz
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft - Morningstar
Companion Spine’s Power Play: Reassembling the Band and Rewriting the Spine Market - Orthopedics This Week
Tangible book value per share of Xtant Medical Holdings, Inc. – DUS:XMS - TradingView — Track All Markets
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):